Trials / Completed
CompletedNCT02165618
Rationalisation of Polypharmacy by the Geriatric Consultation Team
Rationalisation of Polypharmacy by the Geriatric Consultation Team Using the RASP List: a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Accepted
Summary
Polypharmacy is a common problem in elderly, leading among others to increased adverse drug events. The aim of this pilot study was to evaluate whether a systematic medication evaluation by a geriatric consultation team using the RASP (Rationalisation of drugs on admission by an adjusted STOPP\*-list in older patients) list could reduce inappropriate prescribing for elderly admitted patients, admitted to non-geriatric departments. (\* = Screening Tool of Older Persons' potentially inappropriate Prescriptions)
Detailed description
Polypharmacy and (potentially) inappropriate prescribing is highly prevalent in the older population, associated with increase health care expenditures, morbidity and avoidable adverse events . The aim of this pilot study was to evaluate whether a systematic medication evaluation by a geriatric consultation team (GCT) using the RASP (Rationalisation of drugs on admission by an adjusted STOPP-list in older patients) list could reduce inappropriate prescribing for older admitted patients, admitted to non-geriatric departments. The GCT could offer the ideal format to deliver the intervention to a broad older hospitalised population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medication review, based on but not limited to the RASP list | Systematic approach: 1. Medication reconciliation 2. Applying the RASP list 3. Expert review (not based on the RASP list) 4. Multidisciplinary discussion |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2014-06-17
- Last updated
- 2014-06-17
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02165618. Inclusion in this directory is not an endorsement.